×
About 1,138 results

ALLMedicine™ Molluscum Contagiosum Center

Research & Reviews  313 results

Monkeypox: a new global health emergency with predominant dermatological manifestations.
https://doi.org/10.1111/ijd.16504
International Journal of Dermatology; Dogra S, Mehta H et. al.

Nov 23rd, 2022 - Monkeypox is a zoonotic virus belonging to the Orthopoxvirus genus. Previously endemic to Africa, outbreaks have been reported from all over the world, the largest of which is currently ongoing. Dermatologists are principally involved in recogniti...

A Patient-Centered Perspective of Molluscum Contagiosum as Reported by B-SIMPLE4 Clinic...
https://doi.org/10.1007/s40257-022-00733-9
American Journal of Clinical Dermatology; Browning JC, Cartwright M et. al.

Oct 27th, 2022 - Molluscum contagiosum is often characterized by persistent lesions and bothersome symptomology. What patients with molluscum contagiosum and/or caregivers consider to be meaningful measures of therapeutic success is unknown. We aimed to collect pa...

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Oct 14th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

How to handle pesky molluscum contagiosum lesions
https://www.mdedge.com/dermatology/article/258409/pediatrics/how-handle-pesky-molluscum-contagiosum-lesions
Doug Brunk

Oct 4th, 2022 - Some pediatricians believe that molluscum contagiosum (MC) should not be treated because they usually self-resolve in 6-18 months, but Rebecca Smith, MD, sees things differently. “If you don’t treat them, they’re going to spread,” Dr.

Influence of Dietary Nitrate on Skin Inflammation
https://clinicaltrials.gov/ct2/show/NCT03183830

Sep 27th, 2022 - Nitric oxide (NO) is an important substance produced continuously by all blood vessels. It is thought to maintain health, in part, by preventing and suppressing inflammatory responses. NO is normally generated at the endothelium by a group of impo...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  14 results

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Oct 14th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

Influence of Dietary Nitrate on Skin Inflammation
https://clinicaltrials.gov/ct2/show/NCT03183830

Sep 27th, 2022 - Nitric oxide (NO) is an important substance produced continuously by all blood vessels. It is thought to maintain health, in part, by preventing and suppressing inflammatory responses. NO is normally generated at the endothelium by a group of impo...

MC RCT - BPO vs Adapalene
https://clinicaltrials.gov/ct2/show/NCT05536882

Sep 13th, 2022 - During the course of their normal workday, OU dermatology faculty and residents will be responsible for identifying and recruiting treatment-naïve patients being seen at the OU dermatology clinic for the diagnosis of molluscum contagiosum. These s...

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
https://clinicaltrials.gov/ct2/show/NCT03336372

Apr 1st, 2022 - Patients at least 18 years of age will be enrolled in the study to assess the efficacy and tolerability of Picato gel in the treatment of molluscum contagiosum. Patients must have an immunocompromised condition due to taking immunosuppressive drug...

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
https://clinicaltrials.gov/ct2/show/NCT04535531

Aug 13th, 2021 - This is a phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study to be conducted in up to approximately 850 subjects 6 months of age and older with molluscum contagiosum (MC). After obtaining informed consent/asse...

see more →

News  104 results

How to handle pesky molluscum contagiosum lesions
https://www.mdedge.com/dermatology/article/258409/pediatrics/how-handle-pesky-molluscum-contagiosum-lesions
Doug Brunk

Oct 4th, 2022 - Some pediatricians believe that molluscum contagiosum (MC) should not be treated because they usually self-resolve in 6-18 months, but Rebecca Smith, MD, sees things differently. “If you don’t treat them, they’re going to spread,” Dr.

Fauci: COVID Lives On; Doc's Burnout Broke Her Heart; Don't Cook Chicken in NyQuil
https://www.medpagetoday.com/infectiousdisease/covid19/100814

Sep 20th, 2022 - Note that some links may require subscriptions. A day after President Biden said the "pandemic is over," his chief medical advisor Anthony Fauci, MD, said: "we are not where we need to be if we are going to quote 'live with the virus,' because we ...

Atopic dermatitis and infectious cutaneous disorders: What is the link?
https://www.mdedge.com/dermatology/article/256553/atopic-dermatitis/atopic-dermatitis-and-infectious-cutaneous-disorders

Jul 27th, 2022 - Key clinical point: Risk for cutaneous infectious diseases is significantly higher in adults and children with atopic dermatitis (AD) than individuals without AD, with the risk for molluscum contagiosum being the highest. Major finding: Patients w.

Berdazimer gel beats vehicle for molluscum contagiosum in phase 3 study
https://www.mdedge.com/dermatology/article/256313/pediatrics/berdazimer-gel-beats-vehicle-molluscum-contagiosum-phase-3
Heidi Splete

Jul 15th, 2022 - Treatment with berdazimer gel, a novel, topical nitric oxide–releasing agent, significantly improved clearance of molluscum contagiosum lesions, compared with placebo, in a study of 891 individuals at 55 clinics. Molluscum contagiosum (MC) remains.

Berdazimer Gel Beats Vehicle for Molluscum Contagiosum in Phase 3 Study
https://www.medscape.com/viewarticle/977343

Jul 15th, 2022 - Treatment with a berdazimer gel, a novel, topical nitric oxide–releasing agent, significantly improved clearance of molluscum contagiosum lesions, compared with placebo, in a study of 891 individuals at 55 clinics. Molluscum contagiosum (MC) remai...

see more →

Patient Education  10 results see all →